Bank Of Montreal Atai Life Sciences N.V. Transaction History

Bank Of Montreal

  • $214 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$1.5 - $2.19 $211,038 - $308,115
140,692 New
140,692 $277,000
Q3 2023

Nov 01, 2023
BUY
$1.27 - $2.28 $1.23 Million - $2.21 Million
971,455 New
971,455 $1.25 Million
Q2 2022

Aug 11, 2022
BUY
$3.03 - $5.32 $4.47 Million - $7.85 Million
1,474,975 New
1,474,975 $5.44 Million

Others Institutions Holding ATAI

# of Institutions
87
Shares Held
12.4M
Call Options Held
77.8K
Put Options Held
50.3K
View Full List

About ATAI Life Sciences N.V.

ATAI Quotes by TradingView
  • Ticker ATAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 165,875,008
  • Market Cap $197M
  • Description
  • Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...
More about ATAI
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email